New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment.
Goldstein
L E
LE
Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA. goldstle@helix.mgh.harvard.edu
Sporn
J
J
Brown
S
S
Kim
H
H
Finkelstein
J
J
Gaffey
G K
GK
Sachs
G
G
Stern
T A
TA
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy; D016883:Diabetic Ketoacidosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine